GHO

Garry Menzel joins GHO Capital as Operating Partner

Retrieved on: 
Dienstag, April 23, 2024
Diamond, Credit Suisse, Doctor of Philosophy, Goldman Sachs, Stanford University, University, DSM-IV codes, Partner, ADAP, M.B.A, Immunotherapy, Molecular biology, Patient, Operating partner, GHO, Clinical trial, Therapy, Health, Biotechnology, Head, Pharmaceutical industry

London, UK – 23 April 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce the appointment of Dr. Garry Menzel as Operating Partner.

Key Points: 
  • London, UK – 23 April 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce the appointment of Dr. Garry Menzel as Operating Partner.
  • As Operating Partner, Garry will leverage his extensive biotech industry experience in building innovative businesses to guide the GHO portfolio to deliver market leading services to the emerging biopharma space, as well as supporting GHO with deal origination across Europe and the US.
  • On behalf of the entire GHO team, we wish him a warm welcome.”
    Commenting on his new appointment, Garry Menzel, Operating Partner at GHO Capital, said: “Throughout my career, I have been committed to bringing forward the highest possible innovative standards for patients within the healthcare system whilst creating long-term investor value.
  • I am excited to support GHO Capital, as Europe’s leading healthcare specialist private equity firm, to pursue the same goal.

Garry Menzel joins GHO Capital as Operating Partner

Retrieved on: 
Dienstag, April 23, 2024
Diamond, Credit Suisse, Doctor of Philosophy, Goldman Sachs, Stanford University, University, DSM-IV codes, Partner, ADAP, M.B.A, Immunotherapy, Molecular biology, Patient, Operating partner, GHO, Clinical trial, Therapy, Health, Biotechnology, Head, Pharmaceutical industry

London, UK – 23 April 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce the appointment of Dr. Garry Menzel as Operating Partner.

Key Points: 
  • London, UK – 23 April 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce the appointment of Dr. Garry Menzel as Operating Partner.
  • As Operating Partner, Garry will leverage his extensive biotech industry experience in building innovative businesses to guide the GHO portfolio to deliver market leading services to the emerging biopharma space, as well as supporting GHO with deal origination across Europe and the US.
  • On behalf of the entire GHO team, we wish him a warm welcome.”
    Commenting on his new appointment, Garry Menzel, Operating Partner at GHO Capital, said: “Throughout my career, I have been committed to bringing forward the highest possible innovative standards for patients within the healthcare system whilst creating long-term investor value.
  • I am excited to support GHO Capital, as Europe’s leading healthcare specialist private equity firm, to pursue the same goal.

Chainlink Announces General Availability for CCIP

Retrieved on: 
Mittwoch, April 24, 2024
Ethereum, Blog, Chain-link fencing, Avalanche, TVL, LINK, Blockchain, RWA, Growth, Early access, CCIP, Polygon, Vernacular, USDC, Software, Level, GHO, SAN, ETH, Cryptocurrency

SAN FRANCISCO, April 24, 2024 /PRNewswire/ -- Chainlink, the industry-standard decentralized computing platform, announced today that the Chainlink Cross-Chain Interoperability Protocol (CCIP) has officially entered General Availability (GA). Any developer can now permissionlessly use CCIP to securely transfer onboarded tokens cross-chain, send arbitrary messages to smart contracts on another blockchain, or simultaneously send data and value together through CCIP's unique support for Programmable Token Transfers. Supported blockchains include Arbitrum, Avalanche, Base, BNB Chain, Ethereum, Kroma, Optimism, Polygon, and WEMIX, with many more to come in the future.

Key Points: 
  • SAN FRANCISCO, April 24, 2024 /PRNewswire/ -- Chainlink , the industry-standard decentralized computing platform, announced today that the Chainlink Cross-Chain Interoperability Protocol (CCIP) has officially entered General Availability (GA).
  • "The mainnet general availability of CCIP is something that makes it even easier for developers to quickly adopt CCIP as a secure mechanism for cross-chain connectivity."
  • CCIP is also part of the broader Chainlink platform that features additional critical data and computation resources needed to create secure and liquid tokenized real-world asset (RWA) markets.
  • To learn how CCIP helps the industry overcome the historical exploits that have plagued the cross-chain ecosystem, watch Chainlink Co-Founder Sergey Nazarov explain how CCIP is the only interoperability protocol with level-5 cross-chain security.

CobbleStone Software Included in Top 10 AI Healthcare Solution Providers in 2023 by GHO

Retrieved on: 
Dienstag, Januar 16, 2024
CLM, Software, EVP, SPARK, Machine learning, Metadata, Cobblestone, AI, HIPAA, GHO, Health, Medical device

PRINCETON, N.J., Jan. 16, 2024 /PRNewswire-PRWeb/ -- CobbleStone Software – a recognized Leader in contract lifecycle management (CLM) according to the SPARK Matrix™ 2023 Report– was recently interviewed by GHO following the announcement of the Top 10 AI Healthcare Solution Providers list.

Key Points: 
  • PRINCETON, N.J., Jan. 16, 2024 /PRNewswire-PRWeb/ -- CobbleStone Software – a recognized Leader in contract lifecycle management (CLM) according to the SPARK Matrix™ 2023 Report – was recently interviewed by GHO following the announcement of the Top 10 AI Healthcare Solution Providers list.
  • "We are thrilled to be included among the Top 10 AI Healthcare Solution Providers.
  • Our dedication to all industries, including healthcare, is unmatched with the aid of our insightful AI tool that has many features beneficial to healthcare professionals."
  • "We are thrilled to be included among the Top 10 AI Healthcare Solution Providers.

Stuart Quin joins GHO Capital as Partner

Retrieved on: 
Donnerstag, Januar 4, 2024
GHO, Partner, Sale, Acquisition, Cinven, Medica, Doctor of Philosophy, Teleradiology, MEDICA Group, Diagnosis, IK Partners, Patient, Pharma, NHS, Capital, London Stock Exchange, Pharmaceutical industry

London, UK – 4 January 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce today that Stuart Quin joins as a Partner.

Key Points: 
  • London, UK – 4 January 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce today that Stuart Quin joins as a Partner.
  • Stuart, who holds a PhD in Immunology, has nearly two decades of experience within private equity, principally at 3i, and in healthcare leadership across Diagnostics, Pharma and Biotech.
  • The Partners at GHO Capital commented: “One of our core principles at GHO in the pursuit of better, faster and more accessible healthcare is that we don’t just invest in companies, we focus on strategic alignment and collaboration with management teams.
  • We are very excited to welcome Stuart to our leadership team to strengthen our ability to build the next generation of healthcare together.”
    Stuart Quin, Partner at GHO Capital, said: “GHO Capital is Europe’s leading healthcare specialist private equity firm, dedicated to making a difference for patients, healthcare systems, and society, whilst delivering long-term sustainable value to stakeholders.

Stuart Quin joins GHO Capital as Partner

Retrieved on: 
Donnerstag, Januar 4, 2024
GHO, Partner, Sale, Acquisition, Cinven, Medica, Doctor of Philosophy, Teleradiology, MEDICA Group, Diagnosis, IK Partners, Patient, Pharma, NHS, Capital, London Stock Exchange, Pharmaceutical industry

London, UK – 4 January 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce today that Stuart Quin joins as a Partner.

Key Points: 
  • London, UK – 4 January 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce today that Stuart Quin joins as a Partner.
  • Stuart, who holds a PhD in Immunology, has nearly two decades of experience within private equity, principally at 3i, and in healthcare leadership across Diagnostics, Pharma and Biotech.
  • The Partners at GHO Capital commented: “One of our core principles at GHO in the pursuit of better, faster and more accessible healthcare is that we don’t just invest in companies, we focus on strategic alignment and collaboration with management teams.
  • We are very excited to welcome Stuart to our leadership team to strengthen our ability to build the next generation of healthcare together.”
    Stuart Quin, Partner at GHO Capital, said: “GHO Capital is Europe’s leading healthcare specialist private equity firm, dedicated to making a difference for patients, healthcare systems, and society, whilst delivering long-term sustainable value to stakeholders.

Joseph Jimenez, Global Quality Leader, Joins Validant Group

Retrieved on: 
Donnerstag, Oktober 5, 2023
Professional Services, Health, FDA, Medical Devices, Consulting, Pharmaceutical, Biotechnology, Multimedia, Teva Active Pharmaceutical Ingredients, GHO, Quality control, Partner, Procter & Gamble, Teva Pharmaceuticals, Mentorship, Pharmaceutical industry, Medical device, Management, Teva, Validation (drug manufacture)

The Validant Group, a leading global provider of comprehensive and innovative regulatory consulting services for the life sciences industry, today announced that Joseph Jimenez has joined the firm as Partner.

Key Points: 
  • The Validant Group, a leading global provider of comprehensive and innovative regulatory consulting services for the life sciences industry, today announced that Joseph Jimenez has joined the firm as Partner.
  • Joseph is a global quality leader with a career spanning nearly 30-years in the pharmaceutical, medical device, human tissue, and consumer goods organizations.
  • His experience enhances the Validant Group’s quality assurance and strategic regulatory compliance capabilities.
  • The Validant Group is a global, full-service life science consulting company focused on managing and resolving complex regulatory issues.

Green Brick Partners, Inc. Announces New Land Acquisition in Vero Beach, FL

Retrieved on: 
Mittwoch, Oktober 4, 2023
The Country Club, GHO, Treasure Coast, Golf, Green, Country club, NYSE, Hotel, Grand Harbour

Vero Beach is about 80 miles north of Palm Beach, FL and is an important city in the Treasure Coast area.

Key Points: 
  • Vero Beach is about 80 miles north of Palm Beach, FL and is an important city in the Treasure Coast area.
  • The city features peaceful beaches and is one of the most desirable areas to live in Florida.
  • GHO Homes will be offering higher-end homes with waterfront and golf course views priced from $1.5 to $2.5 million.
  • Construction of the homes is currently slated to start at the end of 2023, and the Company anticipates opening for sales in October 2023.

GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organization

Retrieved on: 
Samstag, Mai 27, 2023
LLP, Partnership, CG, GHO, ERM, Partner, API, AlpInvest Partners, Partners Group, CDMO, Grays International, Acquisition, Pantheon, Growth, ESG, Fine chemical, Financial services, Tax advisor, Sterling

GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organization

Key Points: 
  • GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organization
    Since first partnering with GHO in 2019, Sterling Pharma Solutions has grown rapidly, tripling its revenues and quadrupling its earnings.
  • Sterling handles the development of complex APIs and subsequent scaling up of manufacturing from pre-clinical to commercial scale.
  • We are delighted to welcome Partners Group, which, alongside GHO, will support our ambitious global growth trajectory.
  • Sterling is a leading example of how our deep industry expertise, combined with the GHO growth playbook, can generate long-term, sustainable value.

GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organization

Retrieved on: 
Donnerstag, Mai 25, 2023
LLP, Partnership, CG, GHO, ERM, Partner, API, AlpInvest Partners, Partners Group, CDMO, Grays International, Acquisition, Pantheon, Growth, ESG, Fine chemical, Financial services, Tax advisor, Sterling

GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organization

Key Points: 
  • GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organization
    Since first partnering with GHO in 2019, Sterling Pharma Solutions has grown rapidly, tripling its revenues and quadrupling its earnings.
  • Sterling handles the development of complex APIs and subsequent scaling up of manufacturing from pre-clinical to commercial scale.
  • We are delighted to welcome Partners Group, which, alongside GHO, will support our ambitious global growth trajectory.
  • Sterling is a leading example of how our deep industry expertise, combined with the GHO growth playbook, can generate long-term, sustainable value.